Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hess

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Journal of Studies on Alcohol|August 22, 2001
Deficits in recognition of emotional facial expression are still present in alcoholics after mid- to long-term abstinenceC Kornreich, S Blairy, P Philippot, et al.
Leukemia|May 1, 1993
Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromesA Ganser, O G Ottmann, G Seipelt, et al.
Behring Institute Mitteilungen|December 1, 1991
Preclinical and clinical evaluation of interleukin 3A Ganser, O G Ottmann, G Seipelt, et al.
Alcoholism, Clinical and Experimental Research|July 9, 1999
Alcoholics' deficits in the decoding of emotional facial expressionP Philippot, C Kornreich, S Blairy, et al.
Bone Marrow Transplantation|November 29, 2016
Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapseF Gössi, M Spahn, M Zweifel, et al.
Leukemia & Lymphoma|August 13, 2009
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)R Zenhäusern, S-F Hsu Schmitz, M Solenthaler, et al.
Leukemia|January 13, 2006
Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemiaS Meyer-Monard, V Parlier, J Passweg, et al.
Clinical Lymphoma|November 15, 2001
Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cellsG Pichert, S F Schmitz, U Hess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemiasD C Betticher, M F Fey, A von Rohr, et al.
British Journal of Haematology|December 31, 1997
Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, S F Hsu Schmitz, D Ratschiller, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Journal of Studies on Alcohol|August 22, 2001
Deficits in recognition of emotional facial expression are still present in alcoholics after mid- to long-term abstinenceC Kornreich, S Blairy, P Philippot, et al.
Leukemia|May 1, 1993
Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromesA Ganser, O G Ottmann, G Seipelt, et al.
Behring Institute Mitteilungen|December 1, 1991
Preclinical and clinical evaluation of interleukin 3A Ganser, O G Ottmann, G Seipelt, et al.
Alcoholism, Clinical and Experimental Research|July 9, 1999
Alcoholics' deficits in the decoding of emotional facial expressionP Philippot, C Kornreich, S Blairy, et al.
Bone Marrow Transplantation|November 29, 2016
Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapseF Gössi, M Spahn, M Zweifel, et al.
Leukemia & Lymphoma|August 13, 2009
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)R Zenhäusern, S-F Hsu Schmitz, M Solenthaler, et al.
Leukemia|January 13, 2006
Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemiaS Meyer-Monard, V Parlier, J Passweg, et al.
Clinical Lymphoma|November 15, 2001
Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cellsG Pichert, S F Schmitz, U Hess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemiasD C Betticher, M F Fey, A von Rohr, et al.
British Journal of Haematology|December 31, 1997
Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, S F Hsu Schmitz, D Ratschiller, et al.
Pageof 10